Marketing Strategy: The Chinese Pharmaceutical Market: Dynamics and a Proposed Investment Strategy

Abstract

The pharmaceutical industry in China has undergone dramatic development over the past two decades. From a poor agricultural country, China has now become a country with an increasingly strong economy and, more significantly, the eighth largest pharmaceutical market in the world with more than US$8bn total sales in 2004. This paper describes the distribution pattern of the pharmaceutical industry in China, explores the reasons of the emergence of this pattern, and provides investment suggestions to foreign investors who are considering moving into the pharmaceutical market in China. Analysis of the Chinese pharmaceutical industry reveals: (1) most pharmaceutical firms are located in the southeastern zone, which includes two well-developed areas and three sub-developed areas; (2) the development of the pharmaceutical industry in China is predominantly driven by economy factors; (3) there is a slightly changing market distribution pattern from the micro angle, while the general pattern remains steady from the macro angle and (4) the pharmaceutical industry in China is extensively fragmented. The major constituent factors of these features are: (1) misconceptions of the profitability and growth of the pharmaceutical industry, (2) unnecessary political competition between regions and (3) excessive exploitation of regional administrative power. Finally, it is suggested that the foreign investors should concentrate on the southeastern zone that includes two well-developed areas and three sub-developed areas.

Keywords

China fragmentation investment market distribution pattern pharmaceutical industry

Get full access to this article

View all access options for this article.

References

National Bureau of Statistics of China (2004). The Chinese High-tech Industry Statistics Yearbook, 2004, China Statistics Press, Beijing, China.

Souyi

H. E.

Huseng

A. N.

(1999). Regional Economics (1st edn), Economic Sciences Press, Beijing, China.

Yue

H. U.

(2002). Research on drug industry competition of Hebei province. J. Hebei. Univ. Tech. 31, 87–90.

National Economics Research Database [database on the Internet], Center for Chinese State Council Development Research, Beijing (CN); 2003 (cited 2004 June 8). Available from: http://www.drcnet.com.cn/.

National Statistics Database [database on the Internet]. Chinese National Bureau of Statistics, Beijing (CN); c2003 (cited 2004 June 24). Available from: http://www.stats.gov.cn/.

Zhang

(1999). Principles of Regional Economics (1st edn). China Light Industry Press, Beijing, China.

Jianyong

S. H.

(2002). Chinese Medicine Industry Economy and Development (1st edn). Shanghai Science and Technology Press, Shanghai, China.

Xiusun

X. U.

Wang

(2003). Study on the role of drug administration department on the medical economy development. J. China Pharm. 12, 12–13.

Cai

(2001). Evaluation on international competitiveness of Chinese medical industry. J. Sci. Res. Manage. 22, 127–135.

10.

(2000). Industrial Economics (1st edn). China Higher Education Press, Beijing, China.

11.

Sun

Qiu

(2003). On the entrance barriers of Chinese drug industry. J. Pharm. Prog. 27, 59–62.

12.

Chen

Wang

(2001). On the industrial policy of Chinese drug industry during the transition period. J. China Pharm. 10, 2–3.

13.

Pharmaceutical Administration Database [database on the Internet]. State Food and Drug Administration, Beijing (CN); c2003 (cited 2004 February 2). Available from: http://www.sfda.gov.cn/.

14.

Jiang

F. M.

(2005). Driving forces of international pharmaceutical firms' FDI into China. J. Bus. Strategy 22, 21–39.

15.

China Healthcare Consulting [homepage on the Internet], Beijing: China Healthcare Consulting Group; c2002 (cited 2004 Feb 16). Available from: http://www.chccgroup.com/.